F10 (Harvard Medical School/Dana-Farber Cancer Institute/XOMA/SRI International)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameF10 (Harvard Medical School/Dana-Farber Cancer Institute/XOMA/SRI International)
Drug Alias NameF10 (Harvard Medical School/Dana-Farber Cancer Institute/XOMA/SRI International)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionVirus replication inhibitors
TargetsUpdating
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHarvard Medical School
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDana-Farber Cancer InstituteXoma CorpHarvard Medical School +[4] 
Active IndicationsN/A
Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A
Related LinksN/A